deferoxamine has been researched along with verapamil in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.85) | 18.7374 |
1990's | 12 (46.15) | 18.2507 |
2000's | 3 (11.54) | 29.6817 |
2010's | 10 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Fryer, PR; Green, CJ; Pickford, MA; Sarathchandra, P | 1 |
Bittar, EE; Huang, YP | 1 |
Hornsey, S; Jenkinson, T; Myers, R | 1 |
Doré, C; Fryer, PR; Gower, JD; Green, CJ; Pickford, MA | 1 |
Belzer, FO; Goossens, D; McAnulty, JF; Ploeg, RJ; Southard, JH; Vreugdenhil, P | 1 |
Di Giacomo, C; La Delfa, C; Perez-Polo, JR; Renis, M; Russo, A; Sorrenti, V; Vanella, A | 1 |
Farshi, SS; Hasan, T; Iinuma, S; Ortel, B | 1 |
Bhatnagar, A; Castro, GJ | 1 |
Chagas, AC; Da-Luz, PL; Lopes, EA; Pileggi, F | 1 |
Huang, L; Klitzman, B; Panza, W; Serafin, D; Zavitsanos, G | 1 |
Gloy, J; Greger, R; Hug, MJ; Meyer, TN; Pavenstädt, H; Schollmeyer, P | 1 |
Cokneşelí, B; Köksoy, FN; Köse, H; Soybír, GR; Yalçin, O | 1 |
Köksoy, F; Köse, H; Koyuncu, H; Soybir, G; Topuzlu, C; Yalçin, O | 1 |
Wu, W; Yu, C; Zeng, Z | 1 |
Chakrabarti, SK; Lemieux, N; M'Bemba-Meka, P | 1 |
Asakawa, M; Sugishita, K; Takahashi, T; Usui, S | 1 |
Chattipakorn, N; Chattipakorn, S; Fucharoen, S; Kumfu, S; Settakorn, J; Srichairatanakool, S | 1 |
Chattipakorn, N; Chattipakorn, S; Chinda, K; Fucharoen, S; Kumfu, S | 1 |
Chattipakorn, N; Chattipakorn, S; Fucharoen, S; Kumfu, S | 1 |
Alves, RN; Beletti, ME; Labruna, MB; Levenhagen, MA; Levenhagen, MM; Rieck, SE | 1 |
Chu, L; Chu, X; Cui, L; Liu, Y; Liu, Z; Wang, H; Zhang, J; Zhang, Y | 1 |
Chang, Y; Chu, L; Chu, X; Gao, Y; Guo, H; Liu, Z; Wang, N; Zhang, J; Zhang, X; Zhang, Y; Zhao, X | 1 |
Gogvadze, VG; Kulikov, AV; Maximchik, PV; Vdovin, AS; Zhivotovsky, BD | 1 |
2 review(s) available for deferoxamine and verapamil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Myocardial protection in the occlusion/reperfusion dog model: the role of ischemic necrosis vs reperfusion injury.
Topics: Animals; Coronary Vessels; Deferoxamine; Disease Models, Animal; Dogs; Free Radicals; Iron; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Vasodilator Agents; Verapamil | 1995 |
24 other study(ies) available for deferoxamine and verapamil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Ultrastructural changes in rat lungs after 48 h cold storage with and without reperfusion.
Topics: Allopurinol; Animals; Basement Membrane; Cryopreservation; Deferoxamine; Endothelium, Vascular; Epoprostenol; Lung; Lung Transplantation; Microscopy, Electron; Nifedipine; Organ Preservation; Rats; Rats, Inbred Strains; Reperfusion Injury; Time Factors; Verapamil | 1990 |
The behavior of the ouabain-insensitive sodium efflux in single barnacle muscle fibers toward the microinjection of aluminum.
Topics: Aluminum; Animals; Cadmium; Calcium; Deferoxamine; Egtazic Acid; Gallium; In Vitro Techniques; Magnesium; Microinjections; Muscles; Ouabain; Ryanodine; Scandium; Sodium; Thoracica; Verapamil | 1990 |
The reduction of radiation damage to the spinal cord by post-irradiation administration of vasoactive drugs.
Topics: Animals; Deferoxamine; Dipyridamole; Male; Necrosis; Radiation Injuries, Experimental; Rats; Reperfusion Injury; Spinal Cord; Verapamil | 1990 |
Lipid peroxidation and ultrastructural changes in rat lung isografts after single-passage organ flush and 48-hour cold storage with and without one-hour reperfusion in vivo.
Topics: Animals; Citrates; Cold Temperature; Deferoxamine; Lipid Peroxides; Lung; Lung Transplantation; Male; Perfusion; Preservation, Biological; Rats; Schiff Bases; Time Factors; Verapamil | 1990 |
Effect of pharmacologic agents on the function of the hypothermically preserved dog kidney during normothermic reperfusion.
Topics: Allopurinol; Animals; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Catalase; Cold Temperature; Deferoxamine; Dogs; Free Radicals; Glomerular Filtration Rate; Glutathione; In Vitro Techniques; Kidney; Kidney Transplantation; Organ Preservation; Oxygen; Perfusion; Proteinuria; Sodium; Superoxide Dismutase; Time Factors; Urine; Verapamil | 1988 |
Lipid peroxidation and survival in rats following cerebral post-ischaemic reperfusion: effect of drugs with different molecular mechanisms.
Topics: Allopurinol; Animals; Antioxidants; Brain Ischemia; Deferoxamine; Diltiazem; Lipid Peroxidation; Male; Rats; Rats, Wistar; Reperfusion; Reperfusion Injury; Verapamil; Vitamin E | 1994 |
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cells, Cultured; Deferoxamine; Ferrochelatase; Fibroblasts; Humans; Melanoma; Mice; Microscopy, Fluorescence; Mitochondria; Photochemotherapy; Protoporphyrins; Rats; Skin Neoplasms; Spectrometry, Fluorescence; Tumor Cells, Cultured; Up-Regulation; Urinary Bladder Neoplasms; Verapamil | 1994 |
Effect of extracellular ions and modulators of calcium transport on survival of tert-butyl hydroperoxide exposed cardiac myocytes.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cell Size; Cell Survival; Deferoxamine; Diacetyl; Heart; Lipid Peroxidation; Male; Myocardium; Nifedipine; Oxidants; Peroxides; Propyl Gallate; Rats; Rats, Sprague-Dawley; Sodium; tert-Butylhydroperoxide; Verapamil | 1993 |
Limiting impairment of muscle function following ischemia and reperfusion in rabbits.
Topics: Animals; Calcium Channel Blockers; Deferoxamine; Dimethyl Sulfoxide; Forelimb; Free Radical Scavengers; Male; Muscle Contraction; Muscle, Skeletal; Rabbits; Reperfusion Injury; Time Factors; Verapamil | 1996 |
Hydrogen peroxide increases the intracellular calcium activity in rat mesangial cells in primary culture.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antioxidants; Calcium; Catalase; Cells, Cultured; Chromans; Cytoplasm; Deferoxamine; Dithiothreitol; Flufenamic Acid; Glomerular Mesangium; Hydrogen Peroxide; Lanthanum; Nickel; Piperazines; Pyruvic Acid; Rats; Sulfhydryl Reagents; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1996 |
The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfiram in experimental colitis.
Topics: Acetic Acid; Animals; Calcium Channel Blockers; Catalase; Colitis; Colonic Diseases; Deferoxamine; Disease Models, Animal; Disulfiram; Free Radical Scavengers; Gastrointestinal Agents; Male; Rats; Rats, Inbred Strains; Rats, Wistar; Reactive Oxygen Species; Siderophores; Superoxide Dismutase; Ulcer; Verapamil | 1997 |
Chemoprevention of DMBA-induced mammary gland carcinogenesis--preventive effects of free oxygen radical scavengers.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Calcium Channel Blockers; Carcinogens; Deferoxamine; Female; Free Radical Scavengers; Mammary Neoplasms, Experimental; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Verapamil | 1998 |
[Study on silica induced DNA damage and its influence factor].
Topics: Animals; Calcium; Comet Assay; Cricetinae; Cricetulus; Deferoxamine; DNA Damage; Dose-Response Relationship, Drug; Hydroxyl Radical; Silicon Dioxide; Verapamil | 2002 |
Nickel compound-induced DNA single-strand breaks in chromosomal and nuclear chromatin in human blood lymphocytes in vitro: role of oxidative stress and intracellular calcium.
Topics: Acetylcysteine; Analysis of Variance; Calcium; Catalase; Chromatin; Cytogenetic Analysis; Dantrolene; Deferoxamine; DNA Damage; Egtazic Acid; Humans; In Situ Nick-End Labeling; Lymphocytes; Microscopy, Electron; Mutagenicity Tests; Nickel; Oxidative Stress; Superoxide Dismutase; Thiourea; Verapamil | 2005 |
A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction.
Topics: Aged, 80 and over; Calcium Channel Blockers; Cardiomyopathies; Deferoxamine; Ferritins; Humans; Iron Chelating Agents; Iron Overload; Male; Ventricular Dysfunction, Left; Verapamil | 2009 |
T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice.
Topics: Animals; beta-Thalassemia; Calcium Channels, T-Type; Cell Survival; Cells, Cultured; Deferoxamine; Disease Models, Animal; Fluoresceins; Heterozygote; Immunohistochemistry; Iron; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Verapamil | 2011 |
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
Topics: Animals; Azoles; Base Sequence; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular System; Deferoxamine; Dihydropyridines; Disease Models, Animal; DNA Primers; Heart Rate; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nifedipine; Nitrophenols; Organ Size; Organophosphorus Compounds; Organoselenium Compounds; RNA, Messenger; Ventricular Function, Left; Verapamil | 2012 |
Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.
Topics: Animals; Azoles; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cation Transport Proteins; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Disease Models, Animal; Ferric Compounds; Heart Ventricles; Iron Overload; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nitrophenols; Organophosphorus Compounds; Organoselenium Compounds; Quaternary Ammonium Compounds; Receptors, Transferrin; Verapamil | 2013 |
The spreading process of Ehrlichia canis in macrophages is dependent on actin cytoskeleton, calcium and iron influx and lysosomal evasion.
Topics: Actin Cytoskeleton; Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytochalasins; Deferoxamine; Dog Diseases; Dogs; Ehrlichia canis; Ehrlichiosis; Iron; Lysosomes; Macrophages; Microscopy, Electron, Transmission; Monocytes; Siderophores; Verapamil | 2014 |
Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice.
Topics: Animals; Collagen Type I; Collagen Type III; Deferoxamine; Drugs, Chinese Herbal; Endomyocardial Fibrosis; Iron; Iron Overload; Iron-Dextran Complex; Malondialdehyde; Matrix Metalloproteinase 9; Medicine, Chinese Traditional; Mice; Oxidative Stress; Plant Extracts; Random Allocation; Salvia miltiorrhiza; Superoxide Dismutase; Transforming Growth Factor beta1; Verapamil | 2015 |
Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis.
Topics: Animals; Apoptosis; Calcium Channel Blockers; Cell Line; Collagen; Deferoxamine; Diltiazem; Hepatic Stellate Cells; Iron; Iron Overload; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 13; Mice; Nimodipine; Rats; Tissue Inhibitor of Metalloproteinase-1; Verapamil | 2016 |
Inhibition of P-glycoprotein stimulates cell death under Hypoxia-mimicking conditions.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Hypoxia; Deferoxamine; Doxorubicin; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Siderophores; Verapamil | 2017 |